In a six-month study patients who were found to be depressed had a 7% increased chance of dying and this percentage increased depending on the severity of the depression. Depression is common in patients with advanced cancer and in a significant number of patients it is persistent.
The researchers examined symptoms and mood in patients using a screening method originally devised for postnatal mothers, containing questions on worthlessness, subjective sadness and suicidal thoughts as well as questions about symptoms and pain. Depression affected 29% of patients at the initial screening and 54.5% of surviving patients remained depressed eight weeks later.
Professor Mari Lloyd-Williams from the School of Population, Community and Behavioural Sciences said: “Previous research has shown that stroke patients who were depressed did not regain function as well as other patients and they had a higher risk of dying – all patients who have suffered a stroke are now screened for depression but this is not the case for patients at any stage of cancer.
“We know that a patient’s mental state affects their physical state but not enough is known about why this happens. We believe that when someone is depressed they lose motivation and therefore the will to live.
“Depression affects 25% of patients with advanced cancer but at this stage it is difficult to diagnose. Whilst patients with advanced cancer are clearly very ill they can still be effectively treated for depression but the first step in the treatment is the recognition that the patient is depressed.”
Professor Lloyd-Williams and her team have been awarded £2.5 million to carry out further research in palliative care. They are currently working on a larger study of more than 400 patients to identify what emotional and psychological health problems cancer patients experiencing in order to better understand their mental health needs and how to improve their primary care.
Charlotte Roberts | alfa
TU Dresden biologists examine sperm quality on the basis of their metabolism
29.11.2019 | Technische Universität Dresden
Approaching the perception of touch in the brain
27.11.2019 | Max Planck Institute for Human Cognitive and Brain Sciences
Graphene, a two-dimensional structure made of carbon, is a material with excellent mechanical, electronic and optical properties. However, it did not seem suitable for magnetic applications. Together with international partners, Empa researchers have now succeeded in synthesizing a unique nanographene predicted in the 1970s, which conclusively demonstrates that carbon in very specific forms has magnetic properties that could permit future spintronic applications. The results have just been published in the renowned journal Nature Nanotechnology.
Depending on the shape and orientation of their edges, graphene nanostructures (also known as nanographenes) can have very different properties – for example,...
Using a clever technique that causes unruly crystals of iron selenide to snap into alignment, Rice University physicists have drawn a detailed map that reveals...
University of Texas and MIT researchers create virtual UAVs that can predict vehicle health, enable autonomous decision-making
In the not too distant future, we can expect to see our skies filled with unmanned aerial vehicles (UAVs) delivering packages, maybe even people, from location...
With ultracold chemistry, researchers get a first look at exactly what happens during a chemical reaction
The coldest chemical reaction in the known universe took place in what appears to be a chaotic mess of lasers. The appearance deceives: Deep within that...
Abnormal scarring is a serious threat resulting in non-healing chronic wounds or fibrosis. Scars form when fibroblasts, a type of cell of connective tissue, reach wounded skin and deposit plugs of extracellular matrix. Until today, the question about the exact anatomical origin of these fibroblasts has not been answered. In order to find potential ways of influencing the scarring process, the team of Dr. Yuval Rinkevich, Group Leader for Regenerative Biology at the Institute of Lung Biology and Disease at Helmholtz Zentrum München, aimed to finally find an answer. As it was already known that all scars derive from a fibroblast lineage expressing the Engrailed-1 gene - a lineage not only present in skin, but also in fascia - the researchers intentionally tried to understand whether or not fascia might be the origin of fibroblasts.
Fibroblasts kit - ready to heal wounds
03.12.2019 | Event News
15.11.2019 | Event News
15.11.2019 | Event News
10.12.2019 | Architecture and Construction
10.12.2019 | Information Technology
10.12.2019 | Life Sciences